HOME > ARCHIVE
ARCHIVE
- Nippon Shinyaku: Cost-cutting Helps Boost Operating Profits
June 9, 2003
- Fuso: Weaker Sales of Kindaly, Generic Competition Hit Sales, Profits
June 9, 2003
- Wakamoto: Ethical Eye Drops Boost Sales, Profits
June 9, 2003
- Toyama Chemical: Sales Up 16.4% Despite Slump of Major Products
June 9, 2003
- Meiji Seika Kaisha: Downturn in Sales, Profits Reported
June 9, 2003
- Nippon Chemiphar: Uralyt Contributes to Growth in Sales
June 9, 2003
- Matsumotokiyoshi: 20.1% Rise in Operating Profits to \13.5 Billion
June 9, 2003
- Fukujin: 14.6% Growth in Sales, 71.0% Increase in Net Profits
June 9, 2003
- NHI Pricing System Should Assess Technical Innovation: Mr Nagayama of JPMA
June 9, 2003
- Azwell: Cost-cutting, Better Productivity Boost Sales, Profits
June 9, 2003
- BUSUNESS NEWS IN BIEF
June 9, 2003
- Atol: Consolidated Sales, Profits Declined in FY2002
June 9, 2003
- Eisai Seeks Add'l Indication of Acute Pulmonary Embolism for Cleactor
June 9, 2003
- CORPORATE ROUNDUP NEWS IN BRIEF
June 9, 2003
- Nippon Shinyaku Licenses Acamprosate for Alcohol Dependence from Merck Sante
June 9, 2003
- ON THE MOVE
June 9, 2003
- Suzuken, Astis Agree on Comprehensive Business Tie-up
June 9, 2003
- Add'l Indication of GIST Recommended for Novartis' Glivec
June 9, 2003
- Tanabe Seiyaku: Sales Down 3.9% Due to Business Reorganization
June 2, 2003
- BUSINESS NEWS IN BRIEF
June 2, 2003
ページ
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
